Oncology and Hematology - Clinical Practice - Prova Education

Episodes 1-16 of 45

- Edward Chu, MD
  Peer
- Michael J. Overman, MD
  Peer
6
CME/CE
Keeping Pace in GI Cancer: Advances in Immunotherapy in MSI-H/dMMR Metastatic Colorectal Cancer
Keeping Pace in GI Cancer: Advances in Immunotherapy in MSI-H/dMMR Metastatic Colorectal Cancer
0.25 credits
Keeping Pace in GI Cancer: Advances in Immunotherapy in MSI-H/dMMR Metastatic...
0.25 credits
- Jeffrey S. Weber, MD, PhD
  Peer
3
CME/CE
Kimberly’s Concerning Mole: Exploring First-Line Treatment Strategies for Patients with Advanced Metastatic Melanoma
Kimberly’s Concerning Mole: Exploring First-Line Treatment Strategies for Patients with Advanced Metastatic Melanoma
0.25 credits
Kimberly’s Concerning Mole: Exploring First-Line Treatment Strategies for Pat...
0.25 credits
- Marianne J. Davies, DNP, ACNP, AOCNP
  Peer
- Julie R. Brahmer, MD, MSc
  Peer
4
CME/CE
Addressing Barriers in Managing IRAEs Associated with Immune Checkpoint Inhibitor Therapy
Addressing Barriers in Managing IRAEs Associated with Immune Checkpoint Inhibitor Therapy
0.25 credits
Addressing Barriers in Managing IRAEs Associated with Immune Checkpoint Inhib...
0.25 credits
- Scott Kopetz, MD, PhD
  Peer
- Prof Eric Van Cutsem, MD, PhD
  Peer
6
CME/CE
Latest Clinical Advances in the Treatment of BRAF V600E-Mutated Metastatic Colorectal Cancer
Latest Clinical Advances in the Treatment of BRAF V600E-Mutated Metastatic Colorectal Cancer
0.25 credits
Latest Clinical Advances in the Treatment of BRAF V600E-Mutated Metastatic Co...
0.25 credits
- Scott Kopetz, MD, PhD
  Peer
- Prof Eric Van Cutsem, MD, PhD
  Peer
- Josep Tabernero, MD, PhD
  Peer
8
CME/CE
Optimizing Treatment Selection in BRAF V600E-Mutated Metastatic Colorectal Cancer
Optimizing Treatment Selection in BRAF V600E-Mutated Metastatic Colorectal Cancer
0.25 credits
Optimizing Treatment Selection in BRAF V600E-Mutated Metastatic Colorectal Ca...
0.25 credits
- Richard T. Penson, MD, MRCP
  Peer
- Linda R. Duska, MD, MPH
  Peer
16
CME/CE
Keeping Pace in Women’s Cancer: Focus on Endometrial Carcinoma
Keeping Pace in Women’s Cancer: Focus on Endometrial Carcinoma
0.25 credits
Keeping Pace in Women’s Cancer: Focus on Endometrial Carcinoma
0.25 credits
- Mark A. Socinski, MD
  Peer
- Alexander Drilon, MD
  Peer
11
CME/CE
Keeping Pace: Advances in RET Fusion-Positive NSCLC
Keeping Pace: Advances in RET Fusion-Positive NSCLC
0.25 credits
Keeping Pace: Advances in RET Fusion-Positive NSCLC
0.25 credits
- Mark A. Socinski, MD
  Peer
- Helena Yu, MD
  Peer
8
CME/CE
Keeping Pace: Advances in First-Line Therapy for EGFR-mutated NSCLC
Keeping Pace: Advances in First-Line Therapy for EGFR-mutated NSCLC
0.25 credits
Keeping Pace: Advances in First-Line Therapy for EGFR-mutated NSCLC
0.25 credits
- John Healey, MD
  Peer
- William D. Tap, MD
  Peer
4
CME/CE
A Multidisciplinary Approach to Treatment of Tenosynovial Giant Cell Tumor (TGCT)
A Multidisciplinary Approach to Treatment of Tenosynovial Giant Cell Tumor (TGCT)
0.25 credits
A Multidisciplinary Approach to Treatment of Tenosynovial Giant Cell Tumor (T...
0.25 credits
- Gilberto de Lima Lopes Junior, MD, MBA, FAMS
  Peer
- Kai He, MD, PhD
  Peer
- Jyoti D. Patel, MD, FASCO
  Peer
4
CME/CE
Keeping Pace with Immunotherapy Advances in Non-Small Cell Lung Cancer: Global Lessons
Keeping Pace with Immunotherapy Advances in Non-Small Cell Lung Cancer: Global Lessons
0.25 credits
Keeping Pace with Immunotherapy Advances in Non-Small Cell Lung Cancer: Globa...
0.25 credits
- Mark A. Socinski, MD
  Peer
- Gilberto de Lima Lopes Junior, MD, MBA, FAMS
  Peer
5
CME/CE
Keeping Pace: The Use of Immunotherapy in Mutation-Positive Non-Small Cell Lung Cancer
Keeping Pace: The Use of Immunotherapy in Mutation-Positive Non-Small Cell Lung Cancer
0.25 credits
Keeping Pace: The Use of Immunotherapy in Mutation-Positive Non-Small Cell Lu...
0.25 credits
- William J. Gradishar MD, FASCO, FACP
  Peer
- Peter Schmid, FRCP, MD, PhD
  Peer
6
CME/CE
Perspectives for Clinical Practice: The Latest Advances for HER2-positive Metastatic Breast Cancer
Perspectives for Clinical Practice: The Latest Advances for HER2-positive Metastatic Breast Cancer
0.25 credits
Perspectives for Clinical Practice: The Latest Advances for HER2-positive Met...
0.25 credits
- William D. Tap, MD
  Peer
- John Healey, MD
  Peer
9
CME/CE
Best Practices in the Treatment of Tenosynovial Giant Cell Tumor (TGCT)
Best Practices in the Treatment of Tenosynovial Giant Cell Tumor (TGCT)
0.25 credits
Best Practices in the Treatment of Tenosynovial Giant Cell Tumor (TGCT)
0.25 credits
- Mark A. Socinski, MD
  Peer
- Edward B. Garon, MD, MS
  Peer
4
CME/CE
Keeping Pace: The Role of Immunotherapy After Disease Progression
Keeping Pace: The Role of Immunotherapy After Disease Progression
0.25 credits
Keeping Pace: The Role of Immunotherapy After Disease Progression
0.25 credits
- Jyoti D. Patel, MD, FASCO
  Peer
- Kai He, MD, PhD
  Peer
- Gilberto de Lima Lopes Junior, MD, MBA, FAMS
  Peer
3
CME/CE
Non-Small Cell Lung Cancer: A Global Conversation on Advances in Immunotherapy
Non-Small Cell Lung Cancer: A Global Conversation on Advances in Immunotherapy
0.25 credits
Non-Small Cell Lung Cancer: A Global Conversation on Advances in Immunotherapy
0.25 credits
- Mark A. Socinski, MD
  Peer
- Suresh S. Ramalingam, MD
  Peer
8
CME/CE
Keeping Pace: The Role of Immunotherapy in the Frontline Setting
Keeping Pace: The Role of Immunotherapy in the Frontline Setting
0.25 credits
Keeping Pace: The Role of Immunotherapy in the Frontline Setting
0.25 credits

Prev
1
2
3
Next

1/3